Form 4: Stryker Corp Director Sherilyn McCoy Reports Acquisition of 653 Restricted Stock Units

Director Sherilyn McCoy reports acquisition of 653 Restricted Stock Units (RSUs) in Stryker Corp, deferring share receipt until 2029.

Summary

• On May 9, 2024, Sherilyn S McCoy, a director of Stryker Corp, acquired 653 Restricted Stock Units (RSUs).
• The RSUs vest on the earlier of the date of the 2025 Annual Meeting of Shareholders or May 9, 2025.
• McCoy has elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until May 1, 2029.
• Following the transaction, McCoy beneficially owns 5,868 shares of Stryker Common Stock directly.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock unit acquisition. The deferral of shares suggests a positive, long-term outlook from the director, but it's not a strong indicator.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The director's deferred receipt of shares suggests a long-term positive outlook on Stryker's stock performance.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the alignment of management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages including RSUs are standard practice among large-cap medical technology companies like Stryker, Medtronic, and Johnson & Johnson.
• Deferral of share receipt is a common tax planning strategy used by executives.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director's stock ownership.
• The director's acquisition of RSUs aligns her interests with those of the shareholders.

Key Dates